Quotazione Azione Roche Holding (QX) - RHHBY

Acquistare
Vendere
Le migliori offerte per accedere ai dati in tempo reale
Trade Alert USA
Sottoscrizione Mensile
per soli
52,79 €
Mercati OTC USA
Sottoscrizione Mensile
per soli
25,91 €
Book Mercati OTC USA
Sottoscrizione Mensile
per soli
36,99 €
Prezzi IVA esclusa
After-Hours
Ultimo Scambio
Ultimo: $ 34,55 ◊ 0,00 (0,00%)
Nome Azione Simbolo Borsa Mercato Tipo ISIN Descrizione
Roche Holding (QX) RHHBY Other OTC Azione Roche Holding Ltd S/Adr
  Variazione Variazione % Quotazione Attuale Max Min Apertura Chiusura Ora
  -0,17 -0,49% 34,55 34,72 34,51 34,58 34,72 22:11:19
Prezzo Denaro Prezzo Lettera Spread Spread % Notizie
34,51 34,64 0,13 0,38% - -
Ordini Eseguiti Volume VWAP Controvalore Average Volume Ultime 52 settimane
1.518 357.730 US$ 34,5638 US$ 12.364.494 1.079.569 26,35 - 34,98
Ora Ultimo Ordine Tipo Quantità Ultimo Ordine Prezzo Ultimo Ordine Valuta
22:39:15 formt 2.126 US$ 34,55 USD

Bilanci Roche Holding (QX) - RHHBY

Cap. di Mercato Azioni in circolazione Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 29.8B 862.56M $ 10.45B - 2,85 862.39M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0,00% - -

altre informazioni di bilancio »

Notizie Roche Holding (QX) - RHHBY

Notizie in Tempo Reale relative a Roche Holding (QX) (Other OTC): 0 articoli recenti

Forum Azione Roche Holding (QX) - RHHBY

Nessuna Discussione TrovataCrea Discussione

Performance Storiche Roche Holding (QX) - RHHBY

Periodo † Apert. Max Min VWAP Vol Min Vol Max Med. Vol. Giorn. [m] Var %
1 Sett.3434,8733,9634,36041M3M2M0,551,62%
1 Mese32,737534,8732,28433,6758587k3M1M1,81255,54%
3 Mesi33,80534,8731,80533,3906324k4M1M0,7452,20%
6 Mesi31,2734,9829,4533,0000319k6M1M3,2810,49%
1 Anno26,43934,9826,3531,5239287k6M1M8,11130,68%
3 Anni31,4136,8225,2530,7284287k12M1M3,1410,00%
5 Anni3738,540,00050732,1163240k12M1M-2,45-6,62%

Roche Holding (QX) Description

Headquartered in Basel, Switzerland, Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare - a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in-vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy. In 2017, the Roche Group employed about 94,000 people worldwide, invested 10.4 billion Swiss francs in R&D and posted sales of 53.3 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit roche.com
La tua Cronologia
USOTC
RHHBY
Roche Hold..
Registrati ora per visualizzare questi strumenti nella tua watchlist streaming.

Il Monitor ADVFN ti permette di visualizzare fino a 110 titoli ed è completamente gratuito.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V: D:20190616 19:55:01